Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of dl-methylephedrine and pseudoephedrine on dopamine transporter and brain function in healthy males
jRCTs031200205Completed
- Sponsor
- Japan Anti-Doping Agency
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of methylephedrine, Dellegra, pseudoephedrine and fexofenadine (3 arms), sponsored by Japan Anti-Doping Agency. Primary endpoint: Change in dopamine transporter binding potential. Started Nov 2020; status: completed.
02
Drugs
methylephedrineDellegrapseudoephedrinefexofenadine
Beyond the preview
Go deeper on jRCTs031200205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200205.